Uploaden
Importeren
Log in
Registreren
Targeting of NSCLC in 2011
2
Bekeken
0
0
Delen
administrator
07/30/23
abonneren
0
Targeting of NSCLC in 2011
categorie
Laat meer zien
0 Comments
Sorteer op
Top Reacties
Laatste Reacties
Publiceren
Geen reacties gevonden
Facebook Reacties
Volgende
Automatisch afspelen
00:04:28
Amyloidosis - Rare Disease Day 2011 My Story
administrator
3 Bekeken
00:03:11
Targeting ฮฒ-amyloid and tau in Alzheimer's disease
administrator
2 Bekeken
00:02:30
Emerging AL amyloidosis treatments: immunotherapies & targeting amyloid plaque deposits
administrator
4 Bekeken
01:15:45
Does Ovarian Cancer Start in the Fallopian Tubes? February 8, 2011
administrator
3 Bekeken
00:11:42
Green Laning Devon - DTRF Teign to Tamar April 2011 Part 2
administrator
4 Bekeken
00:02:03
DTRF @ BMAD 2011
administrator
2 Bekeken
00:05:45
Childhood Cancer (Ewing Sarcoma)- The Seany Foundation 2011
administrator
4 Bekeken
00:02:17
STEAP1 targeting CAR-T therapy for solid tumors
administrator
0 Bekeken
00:02:17
STEAP1 targeting CAR-T therapy for solid tumors
administrator
2 Bekeken
00:29:54
Patient Perspective and Dr. Sardi (part 1) June 2011 PMP Symposium
administrator
1 Bekeken
00:29:29
Intro and Dr. Sugarbaker (part 1) June 2011 PMP Symposium
administrator
1 Bekeken
00:45:52
2020 Targeting ALK - From Discovery to Frontline Treatment
administrator
5 Bekeken
00:39:36
Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
administrator
4 Bekeken
00:01:10
Pro-inflammatory tumor profile predicts PCR in NSCLC to neoadjuvant chemoimmunotherapy
administrator
2 Bekeken
00:59:21
Rural Doctors Broadcasts Dermatology: Skin Cancer September 2011
administrator
3 Bekeken
00:28:00
Melanoma 2011 and Beyond
administrator
11 Bekeken
00:01:23
Study: New immunotherapy shows promise in targeting pancreatic cancer tumors
administrator
5 Bekeken
00:02:26
Targeting chronic inflammation in MPNs
administrator
3 Bekeken
00:06:58
FDA Approvals in NSCLC and Soft Tissue Sarcoma, Priority Review in Bladder Cancer, and More
administrator
1 Bekeken
00:06:23
Unresectable NSCLC - Tumor Mutational Burden (TMB), the Value in Testing
administrator
1 Bekeken
Last mer
Delen
insluiten
Huis
Artikler
Laatste video's
Trending
Top video's
Films
Populaire kanalen
Korte broek
Categorieรซn
Borstkanker
anders
Kies een betaal methode
Taal
English
Arabic
Dutch
French
German
Russian
Spanish
Turkish
Hindi
Chinese
Urdu
Indonesian
Croatian
Hebrew
Bengali
Japanese
Portuguese
Italian
Persian
Swedish
Vietnamese
Danish
Filipino
Betaal per portemonnee
Geen reacties gevonden